OSCR Share Price Performance
US$11.47
-1.50 (-11.57%)
27.3% undervalued intrinsic discount
US$15.78
Fair Value
Price US$11.47
AnalystConsensusTarget US$15.78
AnalystHighTarget US$23.00
qnsg US$45.34
Fair ValueUS$15.78
Share Pricen/a
Oscar Health, Inc. Stock Price
- 4 Narratives written by author
- 1 Comments on narratives written by author
- 167 Fair Values set on narratives written by author
OSCR Community Narratives
AN
Fair Value US$15.78 27.3% undervalued intrinsic discount
Analysts Raise Oscar Health Price Target amid Profitability Hopes and New Healthcare Initiatives
2users have liked this narrative
1users have commented on this narrative
110users have followed this narrative
AN
Fair Value US$23 50.1% undervalued intrinsic discount
Telemedicine, AI, And Demographics Will Forge A New Insurance Era
1users have liked this narrative
0users have commented on this narrative
20users have followed this narrative
QN
qnsg·
Fair Value US$45.34 74.7% undervalued intrinsic discount
Oscar Health will leverage AI technology for future growth and revenue streams
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Oscar Health will leverage AI technology for future growth and revenue streams
Oscar Health is expanding its membership base at roughly 30% year-over-year, surpassing 2 million members, while maintaining $3.5 billion in cash reserves to absorb short-term losses and invest in growth. Its proprietary +Oscar platform differentiates the company from traditional insurers through AI-driven care navigation, predictive analytics, and telehealth integration—creating opportunities for higher-margin, recurring revenue streams in the future.Read more
55
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Telemedicine, AI, And Demographics Will Forge A New Insurance Era
Key Takeaways Aggressive AI-driven cost reductions and digital adoption could significantly expand margins and drive faster-than-expected profitability and operating leverage. Strong membership and revenue growth, helped by market share gains and new strategic partnerships, position Oscar to outpace competitors and capitalize on long-term healthcare trends.Read more
98
users have viewed this narrative1users have liked this narrative
0users have commented on this narrative
20users have followed this narrative
AN
US$23
50.1% undervalued intrinsic discount
Fair Value
Profit Margin
3.82%
Future PE
11.02x
Price in 2029
US$28.13
Rising Medical Losses And Regulatory Risks Will Erode Future Margins
Key Takeaways Heavy dependence on the ACA individual market and cost-saving technology exposes Oscar Health to revenue pressure from regulatory, competitive, and policy risks. Persistent medical cost increases and industry consolidation threaten profitability, market share, and the company's long-term earnings outlook.Read more
78
users have viewed this narrative1users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$10
14.7% overvalued intrinsic discount
Fair Value
Profit Margin
2.39%
Future PE
11.99x
Price in 2029
US$12.23
Analysts Raise Oscar Health Price Target amid Profitability Hopes and New Healthcare Initiatives
Key Takeaways Higher claims costs and evolving policy risks threaten profitability and future membership growth, despite efforts to reprice plans and leverage digital adoption trends. Regulatory shifts and industry consolidation could inflate expenses and hinder Oscar's ability to realize anticipated technology-driven cost advantages and margin improvements.Read more
784
users have viewed this narrative2users have liked this narrative
1users have commented on this narrative
110users have followed this narrative
AN
US$15.78
27.3% undervalued intrinsic discount
Fair Value
Profit Margin
2.3%
Future PE
17.65x
Price in 2029
US$19.26
Trending Discussion
Recently Updated Narratives
QN
Oscar Health will leverage AI technology for future growth and revenue streams
Fair Value: US$45.34 74.7% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
OSCR: Exchange Enrollment Resilience And Subpoena Overhang Will Shape 2026 Outlook
Fair Value: US$23 50.1% undervalued intrinsic discount
20 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
OSCR: Subsidy Expiration Risk Will Pressure Exchange Enrollment And Profitability
Fair Value: US$10 14.7% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Oscar Health, Inc. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -1.49
- 14.38%
- -3.79%
- 43.9%
About OSCR
- Founded
- 2012
- Employees
- 2305
- CEO
- WebsiteView website
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
